Used as an intermediate in pharmaceutical synthesis, particularly in Suzuki-Miyaura cross-coupling reactions to form biaryl compounds. Its boronate ester group enables efficient carbon-carbon bond formation, making it valuable in the development of active pharmaceutical ingredients (APIs). Commonly applied in the preparation of drug candidates targeting central nervous system disorders and oncology due to the morpholine moiety’s favorable pharmacokinetic properties. Also utilized in medicinal chemistry for structure-activity relationship (SAR) studies to optimize lead compounds.